16 Live Notices for Liting de agentes inmunosupresores
Showing 1 to 16
Selective Immunosuppressants - Tofacitinib Ii.
12 Dec 2024
15 Jan 2025Ozanimod-Containing Medicinal Products
Selective Immunosuppressants - Basiliximab
Supplies Of Medicinal Products With The Active Substance Vedolizumab 2024
Selective Immunosuppressants - Basiliximab
Drug Supplies – Active Ingredient Adalimumab – Atc L04Ab04
Si - Ozanimod I.
Selective Immunosuppressants - Ozanimod I.
Lp With The Content Of Vismodegib 2024
Supplies Of Medicinal Products For Drug Programs And Various Drugs
The Medicine Ravulizumab
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Abatacept (Atc Code: L04Aa24).
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Certolizumab Pegol (Atc Code: L04Ab05).
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Tocilizumab (Atc Code: L04Ac07).
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products With The Active Ingredient Fingolimod (Atc Code: L04Aa27).
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With § 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Infliximab (Atc Code: L04Ab02).
Tenders by Country